Overview Fundamentals API Earnings EOD API Sample Code Pricing

Hoth Therapeutics Inc (HOTH NASDAQ) stock market data APIs

$0.81 0.07(9.4%) as of December 26, 2024
Price chart is built with Anychart

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-004 for treatment of asthma and allergies using inhalational administration; and HT-003 for the treatment of acne and psoriasis, as well as inflammatory bowel diseases. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; Virginia Commonwealth University; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.

Hoth Therapeutics Inc Financial Data Overview

0.7442
0.81
-
0.8174
0.7011
0.58-1.69
5 433 K
6 904 K
0
-0.31
0.844
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'HOTH',
Type: 'Common Stock',
Name: 'Hoth Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00H0HZ8S8',
ISIN: NULL,
CUSIP: NULL,
CIK: '1711786',
EmployerIdNumber: '82-1553794',
FiscalYearEnd: 'December',
IPODate: '2019-02-15',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Hoth Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -14 100 397
  • Earnings Per Share -1.27
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Hoth Therapeutics Inc Earnings via APIs

  • Latest Release 2024-11-11
  • EPS/Forecast -0.34

Get Hoth Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com
Chat